SGC-CAF382-1
Based on 1 Customer Validation
CAF-382 (compound B1) is an analog of SNS-032 and a CDKL5 and pan-CDK inhibitor with a weak GSK3α/β affinity (>1.8 μM) and inhibitory activity. CAF-382 inhibits CDKL5 and blocks the phosphorylation of the CDKL5 E2 domain.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98.15%
- Fòrmula: C16H22N4O2S2
- Peso molecular:366.50
-
Almacenamiento:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
IC50 & Target
IC50: ≤100 nM (CDK9, PCTK1/CDK16, PCTK2/CDK17, PCTK3/CDK18), 2.1-2.7 μM (CDKL3, CDKL4)[1]
In Vitro
CAF-382 (compound B1) (5 nM-5 μM) causes a significant reduction in pSer222 EB2 at 5 nM without a change in total EB2 levels[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Peso molecular 366.50
-
Fòrmula C16H22N4O2S2
-
Color White to light yellow
-
SMILES
CC(C1=CN=C(O1)CSC2=CN=C(S2)NC(C3CCNCC3)=O)C
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Pureza y Documentación
-
Ficha de datos (266 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
SGC-CAF382-1 Related Classifications
HY-155805 Related Classifications
Powered by Bioz